Bioavailable solid dosage forms of metaxalone

Details for Australian Patent Application No. 2005221659 (hide)

Owner Spireas, S.

Inventors Spireas, Spiridon

Agent Watermark

Pub. Number AU-B-2005221659

PCT Pub. Number WO2005/087204

Priority 60/551,257 08.03.04 US

Filing date 8 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 3 July 2008

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/087204 Priority application(s): WO2005/087204

3 July 2008 Application Accepted

  Published as AU-B-2005221659

30 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221660-Laryngeal airway device

2005221656-Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects